Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry

[1]  Deepak L. Bhatt,et al.  Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry , 2016, European heart journal.

[2]  M. Uder,et al.  Adherence to Antihypertensive Medication in Treatment‐Resistant Hypertension Undergoing Renal Denervation , 2016, Journal of the American Heart Association.

[3]  C. Steinwender,et al.  Predictors of response to renal denervation for resistant arterial hypertension: a single center experience , 2016, Journal of hypertension.

[4]  D. Dudek,et al.  Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). , 2016, Kardiologia polska.

[5]  M. Caulfield,et al.  Renal artery sympathetic denervation: observations from the UK experience , 2016, Clinical Research in Cardiology.

[6]  I. Kallikazaros,et al.  Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system. , 2015, International journal of cardiology.

[7]  M. Burnier,et al.  Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis , 2015, Clinical Research in Cardiology.

[8]  P. Gosse,et al.  Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial , 2015, The Lancet.

[9]  R. Whitbourn,et al.  First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension , 2015, Hypertension.

[10]  M. Böhm,et al.  Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension , 2015, Clinical Research in Cardiology.

[11]  J. Václavík,et al.  Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension: Six-Month Results From the Prague-15 Study , 2015, Hypertension.

[12]  Deepak L. Bhatt,et al.  Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. , 2015, European heart journal.

[13]  C. Tsioufis,et al.  The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients: more questions than answers. , 2014, International journal of cardiology.

[14]  M. Uder,et al.  Improvement of albuminuria after renal denervation. , 2014, International journal of cardiology.

[15]  K. Kuck,et al.  Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[16]  S. Kjeldsen,et al.  Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant Hypertension , 2014, Hypertension.

[17]  Deepak L. Bhatt,et al.  Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.

[18]  G. Mancia,et al.  What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[19]  M. Böhm,et al.  Renal denervation for treatment of hypertension and beyond , 2014, Clinical Research in Cardiology.

[20]  M. Andrassy,et al.  Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry , 2014, Clinical Research in Cardiology.

[21]  D. Francis,et al.  Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4121 patients with focus on trial design: the CONVERGE report , 2013, Heart.

[22]  H. Krum,et al.  Renal nerve ablation reduces augmentation index in patients with resistant hypertension , 2013, Journal of hypertension.

[23]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[24]  C. Tsioufis,et al.  Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial , 2013, European heart journal.

[25]  H. Krum,et al.  Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension , 2013, Hypertension.

[26]  P. Anyfanti,et al.  Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. , 2012, Journal of hypertension.

[27]  Symplicity Htn Investigators,et al.  Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months , 2011, Hypertension.

[28]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[29]  W. J. Elliott,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2010 .

[30]  H. Krum,et al.  Renal sympathetic-nerve ablation for uncontrolled hypertension. , 2009, The New England journal of medicine.

[31]  Krzysztof Bartus,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.

[32]  D. Seals,et al.  The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.